Lenalidomide in the Treatment of Mucosal Behçet’s Syndrome
Condition(s):Oral UlcerLast Updated:April 7, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Oral UlcerLast Updated:April 7, 2023Recruiting
Condition(s):Cognitive Impairment, Mild; Cognitive Dysfunction; Amyloid Plaque; Neurodegenerative Disease, Hereditary; Inflammation, BrainLast Updated:December 20, 2023Not yet recruiting
Condition(s):Lymphoma, Mantle-CellLast Updated:October 21, 2022Recruiting
Condition(s):Advanced HCCLast Updated:April 26, 2023Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:October 18, 2023Recruiting
Condition(s):DermatomyositisLast Updated:August 4, 2022Not yet recruiting
Condition(s):Myeloma MultipleLast Updated:March 15, 2024Recruiting
Condition(s):Chemotherapy; Diffuse Large B-Cell Lymphoma (DLBCL), Nos; ElderlyLast Updated:February 8, 2023Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:September 10, 2020Not yet recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:June 16, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.